Placemark Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$23.3M Buy
789,783
+63,588
+9% +$1.82M 0.41% 42
2014
Q3
$20.4M Sell
726,195
-64,933
-8% -$1.82M 0.38% 47
2014
Q2
$22.3M Buy
791,128
+72,384
+10% +$2.06M 0.4% 45
2014
Q1
$21.9M Sell
718,744
-578,907
-45% -$17.3M 0.42% 31
2013
Q4
$37.7M Buy
1,297,651
+332,983
+35% +$9.69M 0.62% 23
2013
Q3
$26.3M Buy
964,668
+46,173
+5% +$1.26M 0.5% 31
2013
Q2
$24.4M Buy
+918,495
New +$25.4M 0.52% 29

Other funds holding PFE

Placemark Investments's PFE Position: Q4 2014 in Review

Placemark Investments increased its Pfizer (PFE) stake by 8.8% in Q4 2014, buying an estimated $1.82M and bringing the position to 789,783 shares worth $23.3M. The position accounts for 0.41% of the portfolio, ranked #42.

Placemark Investments first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $37.7M in Q4 2013. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Placemark Investments held 789,783 shares of Pfizer worth $23.3M as of Q4 2014.
  • Placemark Investments bought 63,588 Pfizer shares in Q4 2014, an estimated $1.82M.
  • Pfizer made up 0.41% of Placemark Investments's portfolio in Q4 2014, its #42 holding.
  • Placemark Investments first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's Pfizer position peaked at $37.7M in Q4 2013.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.